Podcasts

The Safety of Hemophilia Gene Therapy Now and in the Future

Presented by Michael Makris, MA, MB BS, MD, FRCP, FRCPath

Hemophilia Gene Therapy: Expectations for Reliability and Accessibility

Presented by Andrew Leavitt, MD

WFH Gene Therapy Registry

Presented by Barbara A. Konkle, MD and Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

Lentivirus Vectors for Hemophilia Gene Therapy

Presented by Glenn F. Pierce, MD, PhD and Robert Peters, PhD

HTC Readiness: A Multidisciplinary Perspective

Presented by Steven W. Pipe, MD and Debra Pollard, RN

HTC Readiness: A Global Perspective

Presented by Steven W. Pipe, MD and Debra Pollard, RN

Latest Advances in Gene Therapy for Hemophilia in Portuguese

Presented by Margareth Ozelo, MD, PhD

What Do Hemophilia Treatment Centers Need to Consider Now in Preparation for the Anticipated Availability of Gene Therapy?

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Hemophilia Gene Therapy in Patients With History of Inhibitors

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Laboratory Measurement of Hemophilia Gene Therapy Products/Factor Activity

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP